Erratum for Bedetti et al. “Comparison of Prognostic Value of Echocardiacgraphic Risk Score With the Thrombolysis In Myocardial Infarction (TIMI) and Global Registry In Acute Coronary Events (GRACE) Risk Scores in Acute Coronary Syndrome” Am J Cardiol 2010;106:1709–16

2011 ◽  
Vol 107 (8) ◽  
pp. 1253
Keyword(s):  
Myocardial Infarction ◽  
Acute Coronary Syndrome ◽  
Risk Score ◽  
Prognostic Value ◽  
Risk Scores ◽  
Coronary Syndrome ◽  
Coronary Events ◽  
Global Registry

Comparison of Prognostic Value of Echocardiacgraphic Risk Score With the Thrombolysis In Myocardial Infarction (TIMI) and Global Registry In Acute Coronary Events (GRACE) Risk Scores in Acute Coronary Syndrome

2010 ◽  
Vol 106 (12) ◽  
pp. 1709-1716 ◽  
Author(s):  
Gigliola Bedetti ◽  
Luna Gargani ◽  
Rosa Sicari ◽  
Maria Luisa Gianfaldoni ◽  
Sabrina Molinaro ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Coronary Syndrome ◽  
Risk Score ◽  
Prognostic Value ◽  
Risk Scores ◽  
Coronary Syndrome ◽  
Coronary Events ◽  
Global Registry

scholarly journals Comparison of global registry of acute coronary events and thrombolysis in myocardial infarction risk scores in non-ST-elevation acute coronary syndrome

2021 ◽  
Vol 10 (3) ◽  
pp. 106
Author(s):  
RajendraPrasad Satapathy ◽  
Satyanarayan Routray ◽  
Chhabi Satpathy ◽  
NirmalKumar Mohanty ◽  
BijayKumar Dash
Keyword(s):  
Myocardial Infarction ◽  
Acute Coronary Syndrome ◽  
Risk Scores ◽  
Coronary Syndrome ◽  
St Elevation ◽  
Elevation Acute Coronary Syndrome ◽  
Coronary Events ◽  
Global Registry

scholarly journals Risk Scores After Acute Coronary Syndrome

Angiology ◽  
2016 ◽  
Vol 68 (3) ◽  
pp. 185-188 ◽  
Author(s):  
Genovefa D. Kolovou ◽  
Niki Katsiki ◽  
Sophie Mavrogeni
Keyword(s):  
Acute Coronary Syndrome ◽  
Clinical Judgment ◽  
Risk Scores ◽  
Aggressive Treatment ◽  
Future Studies ◽  
Coronary Syndrome ◽  
Short And Long Term ◽  
Coronary Events ◽  
Global Registry

Acute coronary syndrome (ACS) is associated with both short- and long-term unfavorable prognosis. Therefore, medical societies developed risk scores for predicting mortality and assessing decision-making regarding early aggressive treatment in patients presenting an ACS. The Thrombolysis In Myocardial Infarction and the Global Registry of Acute Coronary Events risk scores are the most extensively investigated scores for ACS. Clinical judgment is also important. Significant differences in aggressive treatment of ACS still exist with respect to gender, age, and ethnicity. The reasons for these discrepancies need to be further elucidated in future studies. Therefore, generalizability of stratifications and risk scores in certain populations should be performed with caution.

Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome

2018 ◽  
Vol 25 (8) ◽  
pp. 830-838 ◽  
Author(s):  
Ilaria Cavallari ◽  
Christopher P Cannon ◽  
Eugene Braunwald ◽  
Erica L Goodrich ◽  
KyungAh Im ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Metabolic Syndrome ◽  
Acute Coronary Syndrome ◽  
Prognostic Value ◽  
Independent Predictor ◽  
Adverse Outcomes ◽  
Coronary Syndrome ◽  
The Metabolic Syndrome ◽  
Incremental Value ◽  
Coronary Events

Background The incremental prognostic value of assessing the metabolic syndrome has been disputed. Little is known regarding its prognostic value in patients after an acute coronary syndrome. Design and methods The presence of metabolic syndrome (2005 International Diabetes Federation) was assessed at baseline in SOLID-TIMI 52, a trial of patients within 30 days of acute coronary syndrome (median follow-up 2.5 years). The primary endpoint was major coronary events (coronary heart disease death, myocardial infarction or urgent coronary revascularization). Results At baseline, 61.6% ( n = 7537) of patients met the definition of metabolic syndrome, 34.7% (n = 4247) had diabetes and 29.3% had both ( n = 3584). The presence of metabolic syndrome was associated with increased risk of major coronary events (adjusted hazard ratio (adjHR) 1.29, p < 0.0001) and recurrent myocardial infarction (adjHR 1.30, p < 0.0001). Of the individual components of the definition, only diabetes (adjHR 1.48, p < 0.0001) or impaired fasting glucose (adjHR 1.21, p = 0.002) and hypertension (adjHR 1.46, p < 0.0001) were associated with the risk of major coronary events. In patients without diabetes, metabolic syndrome was numerically but not significantly associated with the risk of major coronary events (adjHR 1.13, p = 0.06). Conversely, diabetes was a strong independent predictor of major coronary events in the absence of metabolic syndrome (adjHR 1.57, p < 0.0001). The presence of both diabetes and metabolic syndrome identified patients at highest risk of adverse outcomes but the incremental value of metabolic syndrome was not significant relative to diabetes alone (adjHR 1.07, p = 0.54). Conclusions After acute coronary syndrome, diabetes is a strong and independent predictor of adverse outcomes. Assessment of the metabolic syndrome provides only marginal incremental value once the presence or absence of diabetes is established.

Accuracy of the Global Registry of Acute Coronary Events (GRACE) Risk Score in Contemporary Treatment of Patients With Acute Coronary Syndrome

2018 ◽  
Vol 34 (12) ◽  
pp. 1613-1617 ◽  
Author(s):  
Mony Shuvy ◽  
Gil Beeri ◽  
Eyal Klein ◽  
Tal Cohen ◽  
Nir Shlomo ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Risk Score ◽  
Coronary Syndrome ◽  
Grace Risk Score ◽  
Coronary Events ◽  
Global Registry
Sign in / Sign up

Export Citation Format

Share Document